Small incisions

Article

Breaking news from the floor of ESCRS

Rayner Intraocular Lenses has been displaying the RaySert, a small incision IOL injector system. With a 1.8 mm diameter external tip, the system is reported to enable surgeons to insert an IOL through a sub 2.5 mm incision, which leads to enhanced patient comfort and recovery.

Adrian Webber, director of sales and marketing at Rayner, explained the appeal of going smaller: “There are big moves among ophthalmic surgeons to implant lenses through smaller incision sizes to fit with their phaco procedures; it reduces the chances of surgically induced astigmatism.” He said that the company is finding that “the smaller the incision the more preferable it is for many surgeons these days.”

“IOL injections through small incisions need not compromise on lens design,” said Ashok Vyas, MD, who has experienced the system first hand.

Designed for use initially with the company’s C-flex range of IOLs, the system assures ease of use with controlled delivery through a single-handed injection system.

“The RaySert is the same overall design as our regular lens injectors,” said Webber. “It is the same loading procedures so that surgeons who are used to our regular lens injector will find with RaySert it is exactly the same except it is now with a smaller incision size.”

“As an innovator in IOL technology, the introduction of the RaySert small incision injector system is a natural progression in delivering physicians with a new level of control and ease in IOL delivery,” says Donald J. Munro, the company’s chairman and managing director.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Harvey Uy, MD, DPBO, FVRSP, speaks about artificial intelligence (AI) and optical coherence tomography (OCT) at the 2025 European Society of Retina Specialists (EURETINA) Congress.
EURETINA 2025: Boris Stanzel, MD, methotrexate is rocking the European retina landscape
Jeremiah Tao, MD, FACS, discusses his Egyptian Ophthalmological Society keynote, which focused on risk management and avoiding surgical complications in oculofacial surgery
© 2025 MJH Life Sciences

All rights reserved.